Sesen Bio, Inc.

ACTIVE

245 1ST St Ste 1800, 马萨诸塞州米德尔塞克斯县, Massachusetts, United Statessesenbio.comPublic1–10 employeesEstablished: 2010-01-01

Part of carisma therapeutics, inc.

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2010

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

60.0%

Phase 1

20.0%

Phase 3

20.0%

Trial Status Distribution

Completed

40.0%

Terminated

60.0%

Clinical Trials

Trials sponsored by this organization (5)

Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG

Phase 3

Completed

interventional

Aug 2015133 participants

Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin

Phase 1

Terminated

interventional

May 200715 participants

Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ

Phase 2

Completed

interventional

Mar 200746 participants

Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer

Phase 2

Terminated

interventional

Jan 200615 participants

Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer

Phase 2

Terminated

interventional

Dec 2005165 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations